DK0430201T3 - - Google Patents

Info

Publication number
DK0430201T3
DK0430201T3 DK90122731.4T DK90122731T DK0430201T3 DK 0430201 T3 DK0430201 T3 DK 0430201T3 DK 90122731 T DK90122731 T DK 90122731T DK 0430201 T3 DK0430201 T3 DK 0430201T3
Authority
DK
Denmark
Prior art keywords
loweralkyl
cycloalkyl
isomer
mixture
physostigmine
Prior art date
Application number
DK90122731.4T
Other languages
Danish (da)
English (en)
Inventor
Yulin Chiang
Edward Joseph Glamkowski
Russell Richard Lee Hamer
Original Assignee
Hoechst Marion Roussel Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Marion Roussel Inc filed Critical Hoechst Marion Roussel Inc
Application granted granted Critical
Publication of DK0430201T3 publication Critical patent/DK0430201T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cephalosporin Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK90122731.4T 1989-11-30 1990-11-28 DK0430201T3 (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/443,682 US5077289A (en) 1989-11-30 1989-11-30 Memory enhancing and analgesic aminocarbonylcarbamates related to physostigmine

Publications (1)

Publication Number Publication Date
DK0430201T3 true DK0430201T3 (pt) 1997-06-16

Family

ID=23761787

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90122731.4T DK0430201T3 (pt) 1989-11-30 1990-11-28

Country Status (23)

Country Link
US (1) US5077289A (pt)
EP (1) EP0430201B1 (pt)
JP (1) JPH0723378B2 (pt)
KR (1) KR100215346B1 (pt)
AT (1) ATE143020T1 (pt)
AU (1) AU626740B2 (pt)
CA (1) CA2031079C (pt)
CZ (1) CZ280888B6 (pt)
DE (1) DE69028605T2 (pt)
DK (1) DK0430201T3 (pt)
ES (1) ES2094742T3 (pt)
FI (1) FI93451C (pt)
GR (1) GR3021210T3 (pt)
HU (1) HU207321B (pt)
IE (1) IE75716B1 (pt)
IL (1) IL96498A (pt)
NO (1) NO175310C (pt)
NZ (1) NZ236248A (pt)
PL (1) PL165775B1 (pt)
PT (1) PT96030B (pt)
RU (1) RU2069664C1 (pt)
YU (1) YU224790A (pt)
ZA (1) ZA909590B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use
AU634654B2 (en) * 1990-05-11 1993-02-25 Hoechst-Roussel Pharmaceuticals Incorporated Pyrrolo(2,3-b)indole-ketones and analogs, a process for their preparation and their use as medicaments
US5173497A (en) * 1990-05-17 1992-12-22 Hoechst-Roussel Pharmaceuticals Incorporated Alpha-oxopyrrolo[2,3-B]indole acetic acids, esters, amides and related analogs
US5480651A (en) * 1992-03-16 1996-01-02 Regents Of The University Of California Composition and method for treating nicotine craving in smoking cessation
FI933264A (fi) * 1992-07-21 1994-01-22 Hoechst Roussel Pharma Foerfarande foer framstaellning av fysostigminkarbamatderivat fraon fysostigmin
US5409948A (en) * 1992-11-23 1995-04-25 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating cognitive disorders with phenserine
US5665880A (en) * 1996-10-31 1997-09-09 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseretholes
US5677457A (en) * 1996-12-19 1997-10-14 Hoechst Marion Roussel, Inc. Method of preparation of physostigmine carbamate derivatives from eseroline ethers
US6495700B1 (en) 2002-01-09 2002-12-17 Axonyx, Inc. Process for producing phenserine and its analog
US20050182044A1 (en) * 2004-02-17 2005-08-18 Bruinsma Gosse B. Combinatorial therapy with an acetylcholinesterase inhibitor and (3aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3,-b]indol-5-yl phenylcarbamate
CA2508585A1 (en) * 2004-06-01 2005-12-01 Axonyx, Inc. Transdermal delivery system for treatment of cognitive disorders
US20050272804A1 (en) * 2004-06-08 2005-12-08 Axonyx, Inc Methods of delaying Alzheimer's disease progression using a beta-amyloid precursor protein inhibitor and a HMG CoA reductase inhibitor
US20080045500A1 (en) * 2004-07-01 2008-02-21 Eisai R&D Management Co., Ltd. Nerve Regeneration Stimulator
US10888542B2 (en) 2014-02-28 2021-01-12 Sk Biopharmaceuticals Co., Ltd. Aminocarbonylcarbamate compounds
TWI698415B (zh) * 2014-02-28 2020-07-11 南韓商愛思開生物製藥股份有限公司 胺基羰基胺基甲酸酯化合物

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1199076B (it) * 1984-03-01 1988-12-30 Consiglio Nazionale Ricerche Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione
US4680172A (en) * 1985-03-05 1987-07-14 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4765985A (en) * 1985-03-05 1988-08-23 Ciba-Geigy Corporation Devices and methods for treating memory impairment
US4791107A (en) * 1986-07-16 1988-12-13 Hoechst-Roussel Pharmaceuticals, Inc. Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use
IT1225462B (it) * 1987-04-03 1990-11-14 Mediolanum Farmaceutici Srl Sali organici di derivati della fisostigmina
US4900748A (en) * 1988-03-04 1990-02-13 The United States Of America As Represented By The Department Of Health And Human Services Carbamates related to (-)-physostigmine as cholinergic agents
US4971992A (en) * 1989-03-27 1990-11-20 Hoechst-Roussel Pharmaceuticals Inc. Carbonate derivatives of eseroline
US4914102A (en) * 1989-09-28 1990-04-03 Hoechst Roussel Pharmaceuticals, Inc. N-aminocarbamates related to physostigmine, pharmacentical compositions and use

Also Published As

Publication number Publication date
ES2094742T3 (es) 1997-02-01
NO905172L (no) 1991-05-31
ZA909590B (en) 1991-09-25
NO175310B (no) 1994-06-20
AU6708590A (en) 1991-06-06
CA2031079A1 (en) 1991-05-31
KR100215346B1 (ko) 1999-08-16
ATE143020T1 (de) 1996-10-15
JPH0723378B2 (ja) 1995-03-15
DE69028605D1 (de) 1996-10-24
CZ280888B6 (cs) 1996-05-15
NO175310C (no) 1994-09-28
IE904308A1 (en) 1991-06-05
EP0430201B1 (en) 1996-09-18
IL96498A (en) 1994-08-26
DE69028605T2 (de) 1997-03-06
CZ594890A3 (en) 1995-02-15
PT96030A (pt) 1991-09-13
JPH03181483A (ja) 1991-08-07
FI93451C (fi) 1995-04-10
HU207321B (en) 1993-03-29
EP0430201A2 (en) 1991-06-05
HUT57773A (en) 1991-12-30
NZ236248A (en) 1993-02-25
US5077289A (en) 1991-12-31
KR910009707A (ko) 1991-06-28
PL165775B1 (pl) 1995-02-28
HU908014D0 (en) 1991-06-28
IL96498A0 (en) 1991-08-16
PT96030B (pt) 1998-01-30
AU626740B2 (en) 1992-08-06
NO905172D0 (no) 1990-11-29
CA2031079C (en) 2001-01-23
FI905855A (fi) 1991-05-31
EP0430201A3 (en) 1992-01-02
GR3021210T3 (en) 1996-12-31
FI905855A0 (fi) 1990-11-28
FI93451B (fi) 1994-12-30
PL288016A1 (en) 1992-06-26
IE75716B1 (en) 1997-09-24
RU2069664C1 (ru) 1996-11-27
YU224790A (sh) 1993-10-20

Similar Documents

Publication Publication Date Title
DK0430201T3 (pt)
AU6208990A (en) N-substituted-4-pyrimidinamines and pyrimidindiamines, a process for their preparation and their use as medicaments
CA2029265A1 (en) 4- and 6-carbamates related to physostigmine, a process and intermediates for their preparation and their use as medicaments
AU636351B2 (en) N-heteroaryl-purin-6-amines, a process for their preparation and their use as medicaments
FI901470A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten 1,2,3,3a,8,8a-heksahydro-1,3a,8-trimetyylipyrrolo/2,3-b/indol-5-yyli-karbonaattiestereiden valmistamiseksi
GR3005904T3 (pt)